Polyphor Ltd Financing Round

Polyphor Ltd, a clinical stage, privately held Swiss specialty pharma company focused on the development of macrocycle drugs addressing antibiotic resistance and respiratory diseases, has completed a CHF 40 m private placement. Existing Polyphor investors, including the anchor investors Varuma AG and Ingro Finanz AG, contributed to 98% of the financing.

VISCHER assisted Polyphor in this transaction. The team at VISCHER was led by Matthias Staehelin with Luzius Zumstein (both Corporate).

Matthias Staehelin

Attorney at Law and Civil Law Notary (BS/BL)

• Partner

• +41 58 211 33 53
• [email protected]

Luzius Zumstein

Attorney at Law

• Managing Associate

• +41 58 211 32 02
• [email protected]